Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Distinguished Abstract
Meeting
Search Results for Adult hemophagocytic lymphohistiocytosis
Abstract Number: 0840
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO EPSTEIN-BARR VIRUS: A COMMON CAUSE OF A RARE DISEASE
SHM Converge 2025
Case Presentation: A 59-year-old female with medical history significant for depression/anxiety, CAD, hypothyroidism, and tobacco use, recently admitted for leukopenia and normocytic anemia thought to be secondary to Epstein Barr Virus (EBV), Parvovirus, and adverse drug event from cefdinir use, presents with persistent fatigue and weight loss to an outside hospital. She was noted to [...]
  • This Week

  • This Month

  • All Time

  • This Week

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS
  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION
  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON
  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS
  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION
  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top